Clopidogrel superior to Aspirin monotherapy after PCI across risk strata: HOST-EXAM analysis Medha Baranwal21 Oct 2023 10:45 AM ISTSouth Korea: A post hoc analysis of HOST-EXAM compared antiplatelet therapies after percutaneous coronary intervention (PCI) according to ischemic,...
Adverse Effects of Proton Pump Inhibitor Use in Patients with Cardiovascular Disease: Pharmacovigilance Attention Needed!! Dr. Kamal Kant Kohli8 Sept 2023 11:30 AM ISTSince the introduction of proton pump inhibitors (PPIs), they have steadily become the mainstay in treating acid-related disorders. The adoption of...
USV Launches Roseday CV at a Patient-Centric Price for Indian Cardiac Patients MD Brand Connect24 Aug 2023 12:04 PM ISTThe recent AHA/ACC 2023 Guidelines for Chronic Coronary Disease recommend considering medication costs to prevent cost-related non-adherence....
Clopidogrel fails to prevent recurrence of heart attack in majority of British south Asians Dr. Kamal Kant Kohli23 Aug 2023 9:00 AM ISTUK: Clopidogrel is a commonly prescribed medication used to prevent further heart attacks after an initial event. It needs to be activated in the body...
Clopidogrel bests aspirin for long-term maintenance after PCI: Analysis of HOST-EXAM Trial Medha Baranwal19 April 2023 11:30 AM ISTKorea: A post hoc analysis of the HOST-EXAM trial has suggested using clopidogrel over aspirin monotherapy, irrespective of diabetes presence, in...
DAPT often under prescribed after TIA or minor stroke, especially in women Dr. Kamal Kant Kohli14 Feb 2023 10:00 AM ISTThere is ample evidence that starting dual antiplatelet therapy shortly after a minor stroke or a transient ischemic attack - TIA may prevent a...
Nuisance bleeding tied to early increase in bleeding risk in patients with acute MI on DAPT: Circulation Medha Baranwal5 Dec 2022 10:15 AM ISTKorea: A subanalysis of the TALOS-AMI trial has shown nuisance bleeding (NB) to be frequent in patients with acute myocardial infarction (AMI) on...
Clopidogrel Bests Aspirin for Secondary Prevention of ASCVD MD Bureau1 April 2022 10:45 AM ISTAntiplatelet therapy is the cornerstone for the prevention and treatment of atherothrombosis. Aspirin is the most widely used antiplatelet agent for...
P2Y12 inhibitors Reduce Ischemic Events in First 2 hours Post PCI MD Bureau2 March 2022 9:30 AM ISTPatients undergoing percutaneous coronary intervention (PCI) are at risk of thrombotic complications including stent thrombosis causing myocardial...
Study Finds New Evidence on Personalized Selection of Antiplatelet Therapy MD Bureau3 Feb 2022 9:00 AM ISTOral P2Y12 inhibitors (clopidogrel, prasugrel, and ticagrelor) used in conjunction with aspirin constitute a key strategy for the prevention of...
Clopidogrel-aspirin decreases recurrent stroke risk in patients with acute infarct on imaging; JAMA Medical Dialogues Editorial Team3 Feb 2022 9:00 AM ISTUSA: According to new research, having an acute infarct on index imaging is related to an increased risk of recurrent stroke and a more noticeable...
22 drug samples fail to qualify CDSCO test, Details Medical Dialogues Team23 Dec 2021 5:31 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 22 medicine...
